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To elucidate the role of the fusion peptide in influenza hemagglutinin (HA)-mediated fusion, we compared pH-dependent
conformational changes and fusion mediated by wild-type and a mutant HA in which Glu residues at positions 11 and 15 of
the fusion peptide are substituted for valine. The pH dependence of conformational changes and kinetics of fusion with
erythrocytes was the same for both forms of HA. The time for commitment and the temperature dependence of HA-mediated
fusion were also the same. However, striking differences were observed between wild-type and mutant fusion peptides in
their interactions with lipid membranes at neutral and acidic pH. Since elimination of the negatively charged residues allows
the exposed fusion peptide to penetrate the bilayer at pH values closer to neutral, but does not affect conformational
changes and fusion activity in intact HA, we conclude that conformational changes are tightly coupled to fusion peptide
insertion in the overall HA-mediated fusion cascade. © 2001 Academic Press
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The fusion of influenza virus membranes with target
membranes is mediated by the major spike membrane
glycoprotein of influenza, the hemagglutinin (HA) (Skehel
and Wiley, 2000). HA is organized in the viral membrane
as a homotrimer. Each monomer consists of two disul-
fide-linked subunits, HA1 and HA2, which are formed
following posttranslational cleavage of the precursor
HA0 (Klenk et al., 1975). Fusion promoted by HA is highly
pH-dependent, proceeding more rapidly at acidic pH
(Clague et al., 1991). There are two factors that may
ontribute to establishing this pH dependence. One is
he pH-dependent conformational change that occurs in
he protein (Skehel et al., 1982) and the other is the
hange in the nature of the interaction of the fusion
eptide with lipids as a function of pH (Durell et al., 1997).
Structural information is available for the ectodomains
of both the native protein at neutral pH (Wilson et al.,
1981) and a portion of HA2 following exposure to low pH
(Bullough et al., 1994). The NH2-terminal residues 1–20 of
HA2 have been designated as the fusion peptide based
on a variety of genetic, protein chemical, and biophysical
studies (Durell et al., 1997). In the native HA structure at
neutral pH, the three fusion peptides are partially buried
between a-helices at the interface between the HA2 and
A1 subunits, near the viral side of the ectodomain stalk
Wilson et al., 1981). These NH2-terminal regions of the
1 To whom correspondence and reprint requests should be ad-
ressed at Center for Cancer Research, P.O. Box B, Bldg. 469, Rm.
16A, Miller Drive, Frederick, MD 21702-1201. Fax: 301 846-6192. E-mail:
lumen@helix.nih.gov.
353A2 sequence adopt sequential turn conformations, sim-
lar to a random coil. Activation of HA at low pH results in
xtensive molecular rearrangements leading to extru-
ion of the fusion peptide from this buried location,
hereupon it can interact with the target (Tsurudome et
l., 1992; Stegmann et al., 1991) and/or viral (Weber et al.,
994) membrane. Determination of the HA structure in
he activated, low-pH state has been hindered by the
xposure of the hydrophobic fusion peptide, which
auses disordered aggregation of the trimers in aqueous
olution. However, the high-resolution structure of a sta-
le truncated recombinant ectodomain of the fusion-pH
onformation of HA2, which lacks the N-terminal 22
mino acids, has been determined at 1.9 Å resolution
Chen et al., 1999). According to this structure, the N- and
-terminal residues of the molecule form an N cap,
erminating both the N-terminal a-helix and the central
coiled coil. Comparison with the crystal structures of a
number of other membrane fusion-inducing proteins re-
veals common structural motifs (Skehel and Wiley, 1998),
which suggest plausible mechanisms for membrane fu-
sion. The most plausible scenario is that activation of the
fusion protein results in release of the fusion peptide and
extension of a central coiled-coil structure (Bullough et
al., 1994). The new positioning of the fusion peptides at
the tip of the stalk provides for easy contact with the
target cell membrane. A small group of proximal fusion
proteins, which are simultaneously inserted into both the
viral and the target membranes, would constitute a po-
tential fusion site (Weissenhorn et al., 1999).
To better understand the mechanistic, structural roles
that the fusion peptide segment of the protein plays in
the fusion process, many studies have been conducted
0042-6822/01 $35.00
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354 KORTE ET AL.with synthetic peptide analogs (Durell et al., 1997; Han
nd Tamm, 2000). These have focused on characterizing
heir conformation, aggregation, and interaction with
embranes. In particular, we were interested in assess-
ng the effect of changing the charge on the fusion
eptide on its ability to promote membrane fusion as
ell as observing the consequences of the same muta-
ions in the intact hemagglutinin protein.
Steinhauer et al. (1995) have shown that substitution of
he glutamic acid residues at positions 11 and 15 of the
usion peptide had no effect on the ability of the mutant
A to undergo the pH-activated conformational changes
nd to mediate syncytia formation at acidic pH. The
ild-type and mature (proteolytically processed) mutant
As were equally expressed on the cell surface and
xhibited the same pH threshold for conformational
hanges and cell fusion activity. Since elimination of the
egatively charged residues would presumably allow the
usion peptide greater accessibility to the bilayer at neu-
ral pH, one possible conclusion would be that the pH
ependence of HA fusion is mainly due to the low pH
nduced conformational changes in HA.
To test this hypothesis we explored the way an HA
usion peptide analog comprising the two mutations in
lutamic acid affects lipid bilayers at neutral and acid
H. We also examined in more detail the activity of these
utations in the intact HA by performing kinetic studies
f fusion of HA-expressing cells with erythrocytes la-
eled with fluorescent lipid dyes.
RESULTS
inetics of HA-mediated cell fusion
HA-mediated fusion may involve two pH-dependent
rocesses. One is the triggering of the conformational
hange in the intact protein and the other is the proto-
ation of the fusion peptide. If the second process dom-
nates, then, in principle, the pH dependence for a mu-
ant HA with fewer charged residues in its fusion peptide
equence should be different from that for the wild-type
A. Steinhauer et al. (1995) found that cosubstitution of
aline for the conserved glutamic acid at position 11 and
he variable glutamic acid at position 15 of HA2 had no
ffect on the formation of heterokaryons which would
nvolve widening of the fusion pore. However, the fusion
ssay used for this study involved a 1-min exposure to
H 5.0 for HA activation; although 1 min is a relatively
hort time, it could still potentially cause the conforma-
ional changes which are necessary for full fusion pore
xpansion. In an attempt to dissect out these two pro-
esses, we measure the kinetics of fusion based on
luorescence dequenching of HA-expressing cells with
18-labeled erythrocytes as a function of pH for both
A-WT and HA-E11V/E15V. At the threshold pH of 5.4 the
luorescence dequenching proceeds very slowly with
imilar kinetics for both HA-WT and HA-E11V/E15V (Fig.
A). At pH 5.2, fusion is more rapid after a lag time which
i
as the same for HA-WT and HA-E11V/E15V, and at pH 5.0
he rates and extents are undistinguishable. Figure 1B
hows that at lower temperature and optimal pH fusion
roceeds after similar delay times of about 70 s for both
A-WT and HA-E11V/E15V.
omparison of conformational changes, fusion, and
eakage rates
Steinhauer et al. (1995) showed the same pH depen-
ence of the conformational changes of HA-WT and
A-E11V/E15V using antibodies to epitopes in HA which
ecome exposed at low pH. Figure 2 shows similar
esults using bis-ANS as a probe for the exposure of
ydrophobic sites in low pH-treated HA (Korte and Herr-
ann, 1994). Interestingly the threshold for fusion is
hifted to a lower pH value than those for the maximal
onformational change.
To separate effects of low pH on conformational
hanges as well as on fusion peptide activity, we used
ynthetic peptides representing the WT and E11V/E15V
equences. These peptides were tested for their ability
o induce leakage of a fluorescent dye, calcein, from
oaded erythrocytes. Figure 2 shows a shift of about 0.2
H units in the ability of the E11V/E15V peptide to induce
eakage as compared to the WT peptide, indicating that
eptide insertion can proceed at a less acid pH in the
ase of the E11V/E15V mutant peptide.
nteractions of fusion peptides with liposomes
We also tested the effect of these peptides on leakage
f contents from liposomes. Figure 3 shows that the WT
eptide did not induce leakage at pH 7.4 even at peptide/
ipid ratios as high as 2. By contrast, the E11V/E15V
eptide induced leakage at neutral pH at peptide/lipid
atios . 1. At pH 5 both peptides induced leakage at
ower peptide/lipid ratios. To mimic the biological situa-
ion we also used “raft lipids” for the peptide-induced
eakage studies (Schroeder et al., 1998), since it has
een proposed that the self-insertion of the fusion pep-
ide is an important element in the fusion process (Guy et
l., 1992; Kozlov and Chernomordik, 1998; Weber et al.,
994; Bentz, 2000), and HA localizes to membrane rafts
Scheiffele et al., 1999). Figure 3B shows similar effects
f WT and E11V/E15V peptides on leakage from lipo-
omes composed of raft lipids, in that at neutral pH the
T peptide did not induce leakage even at relatively high
eptide/lipid ratio, whereas the E11V/E15V peptide in-
uced leakage at peptide/lipid ratio . 1. At low pH both
eptides induced leakage.
Figure 4 shows striking differences in the ability of WT
nd E11V/E15V peptides to promote lipid mixing in lipo-
omes. Whereas WT did not cause any lipid mixing at pH
in cholesterol-containing liposomes (data not shown)
n accordance with Wharton et al., (1988), E11V/E15V
nduced similar rates and extents of lipid mixing at pH 7
nd 5. Moreover, at the low pH WT promoted about 25%
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355FUSION PEPTIDE ACTIVITY OF THE INFLUENZA HEMAGGLUTININof the rate and extent of lipid mixing compared with the
mutant. These results indicate that the exposed E11V/
E15V fusion peptide has greater access to the bilayer at
either pH value.
FIG. 1. Kinetics of fusion of R18-labeled erythrocytes with HA-expres
postinfection with recombinant vaccinia, washed, and suspended in PBS
rythrocytes were added to 2 ml of NaAc buffer with preadjusted pH and
FDQ) as a function of pH at 37°C for cells expressing HA-WT (left) and HA
equenching as a function of temperature at pH 5.0 for cells expressing
FIG. 2. pH dependence of fusion, conformational changes, and
peptide-induced leakage. Relative HA-induced FDQ (F, E), bis-ANS
fluorescence (, ), and leakage induced by peptides (5 mg/ml) (f, h)
ere measured 15 min following incubation at 37°C as a function of
H. The data are normalized to the maximal response at pH 5.0. Closedpymbols: HA-WT or the peptide WT; open symbols: HA-E11V/E15V or
he peptide E11V/E15V.We also examined the effect of the E11V/E15V peptide
on the bilayer to hexagonal transition temperature (TH) of
dipalmitoleoyl phosphatidyl ethanolamine (DiPoPE), as a
measure of its modulation of membrane curvature. Fig-
ure 5 shows that the mutant peptide has little effect on TH
at pH 7.4, shifting it by 83 6 97°C/mol fraction peptide
but at pH 5 the peptide lowers TH by 2167 6 47°C/mol
raction peptide. This compares with the wild-type pep-
ide that shifts TH by 301 6 49 and 2453 6 112°C/mol
fraction peptide at pH 7 and 5, respectively (Epand and
Epand, 1994).
Commitment experiments
In an attempt to further separate effects of low pH on
conformational changes in HA from those on fusion pep-
tide insertion, we performed “commitment” experiments.
We had previously shown that the observed lag time in
HA-mediated fusion (see Fig. 1B) can be dissected into
at least two stages (Blumenthal et al., 1991): A period
equired for commitment of the HAs to a fusogenic state,
hich is pH-dependent, and a “maturation” time required
or the onset of fluorescence dequenching, which is
H-independent. After commitment the process cannot
e stopped by returning to neutral pH and the fusion
H3T3 cells. R18-labeled erythrocytes were added to NIH3T3 cells 12 h
scribed under Materials and Methods. NIH3T3 cells (20 ml) with bound
ature in a temperature-controlled cuvette. (A) Fluorescence dequenching
15V (right). (E) pH 5.0, () pH 5.2, (h) pH 5.4, ({) pH 7.0. (B) Fluorescence
(left) and HA-E11V/E15V (right). (E) 37°C, () 25°C.sing NI
as de
temperroceeds with maximal kinetics (Morris et al., 1989;
Schoch and Blumenthal, 1993). The committed state is
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356 KORTE ET AL.insensitive to treatment with trypsin and DDT, which
releases HA1, but is reversed by treatment with protein-
ase K and thermolysin, which affect HA2 (Schoch et al.,
FIG. 3. Peptide-induced leakage from liposomes. Calcein-loaded LUV
preadjusted pH and temperature and after 120 s the peptide was injec
0)] 3 100, where at Ft is the fluorescence after 15 min of incubation at 3
of peptide. (E, F) WT; (, ) E11V/E15V. Closed symbols: pH 5.0; ope
(1:1:1). (right) Liposomes made of 2:1:1:2 (mole ratio) liver or brain PC:
FIG. 4. Membrane fusion of 150 mM LUVs of DOPC/DOPE/Choles-
erol (1:1:1). LUV promoted by the E11V/E15V and WT fusion peptides,
s determined by lipid mixing at pH 7.0 and 5.0. Peptide aliquots were
dded to mixtures of LUV containing 2% NBD-PE and Rho-PE, and
nlabeled LUV (total lipid concentration, 150 mM; lipid:peptide, 15:1
mol:mol)). The fluorescence intensity upon the addition of reduced
riton X-100 (0.25% v/v)was referred to as 100%. Curve 1, E11V/E15V at
H 5; curve 2, E11V/E15V at pH 7; curve 3, WT at pH 5; curve 4, DMSO
ontrol for E11V/E15V at pH 5; curve 5, DMSO control for E11V/E15V att
n
H 7.4. DMSO control for WT at pH overlaps with curve 5. WT shows no
nhancement over control at pH 7.4.992). The committed state thus represents interactions
etween HA2, presumably including the fusion peptide,
nd the target membrane. To examine the effect of the
11V/E15V mutation in the fusion peptide on this inter-
ction, we measured extents of R18 dequenching follow-
ng a brief low pH pulse as a function of the duration of
he pH pulse. Figure 6 shows that for pH pulses . 30 s
he extent of fluorescence dequenching is maximal, i.e.,
he same as if there was no neutralization. The extent of
equenching varied as a function of the length of the
cid pulse with about 50% maximal dequenching after a
ulse of about 20 s. However, virtually no difference was
een between wild-type and mutant, indicating that the
rocess leading to an irreversible HA2-target membrane
nteraction is independent of the structure of the fusion
eptide. Since the linkage between low pH-induced con-
ormational changes and fusion peptide insertion has not
een severed with the HA-E11V/E15V, whose fusion pep-
ide requires less of a pH shift for insertion, we surmise
hat the conformational changes are tightly coupled to
he process of fusion peptide insertion in the HA-medi-
ted fusion cascade.
DISCUSSION
In these studies of the structural properties of the HA
usion peptide, we have confirmed and extended a num-
er of observations made previously by Steinhauer et al.
1995). Since we were interested in examining the rela-
ionships between low pH-induced conformational
hanges in HA and fusion peptide activity, we have
ocused on the E11V/E 15V mutant HA protein, which did
ot show significant differences in either pH-dependent
onformational changes or syncytia formation. Since the
limination of the negatively charged residues would
resumably allow the fusion peptide to enhance its in-
final lipid concentration of 1.3 mM were added to 2 ml NaAc buffer with
m a solution of DMSO. Percent leakage is given by [(Ft 2 F0)/(Fmax 2
ontrols were done using comparable volumes of DMSO in the absence
ols, pH 7.0. (Left) Liposomes made of DOPC, DOPE, and Cholesterol
omyelin:cerebrosides:cholesterol (“raft” lipids) (Schroeder et al., 1998).s at a
ted froeraction with the membrane at pH values closer to
eutral, we would expect the mutant HA to be more
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357FUSION PEPTIDE ACTIVITY OF THE INFLUENZA HEMAGGLUTININfusion active under less acidic conditions. We reasoned
that the possible differences between fusion activity of
WT and mutant HA at elevated pH values would show up
in our kinetic assays, rather than in syncytia formation,
which is a read out of the end point of the fusion process.
To confirm our supposition that the fusion peptide would
enhance its interaction with the membrane at pH values
closer to neutral, we also examined the biophysics of
interactions of the WT and mutant fusion peptides with
model liposomes.
We show that fusion mediated by HA-WT and HA-
E11V/E15V exhibit almost identical fusion kinetics as a
FIG. 5. Shift of the bilayer to the hexagonal phase transition tempe
peptide at pH 7.4 (squares) and pH 5.0 (circles). Linear regression of th
raction peptide at pH 5.
FIG. 6. Commitment of HA to cell fusion following acid pulses. R18-la
in 50–100 ml PBS pH 7.4 and added to a thermostated cuvette containin
brought back to neutral by addition of a small volume of pretitrated, con
later by measuring fluorescence before and after adding 20 ml 10% T
reneutralization of the medium. HA-WT (left) and HA-E11V/E15V (right).(E) pH
5.0; () 30 s at pH 5.0.function of pH (Fig. 1). Both forms of HA undergo the
same pH-dependent conformational change as shown
by an increase in bis-ANS fluorescence (Fig. 2), which
confirms the antibody binding data of Steinhauer et al.
1995). In addition, commitment of the protein to proceed
ith fusion at neutral pH, after exposure of the HA to pH
at 25°C, shows the same kinetics for both proteins (Fig.
). In contrast to the effects of the double mutation on the
unction of intact HA, the E11V/E15V fusion peptide is
uch more active in perturbing model membranes at
lose to neutral pH than the WT fusion peptide. We
bserved a shift of about 0.2 pH units in the ability of the
of DiPoPE as a function of the mole fraction of the E11V/E15V fusion
yields 83 6 97°C/mol fraction peptide at pH 7.4 and 2167 6 47°C/mol
rythrocytes attached to HA-expressing NIH3T3 cells were suspended
(final volume) PBS-citrate pH 5.0. At various time intervals the pH was
ted Tris solution (about 0.3 M). The final extents were recorded 10 min
-100. They were normalized against fusion extents obtained withoutbeled e
g 2 ml
centra
riton X7.4; () pH 5.0 without neutralization; (h) 10 s at pH 5.0; ({) 20 s at pH
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358 KORTE ET AL.E11V/E15V peptide to induce leakage in erythrocyte
membranes as compared to the WT peptide (Fig. 2). A
more detailed study of liposome leakage as a function of
peptide concentration showed that the E11V/E15V pep-
tide induces leakage at neutral pH as a function of
peptide/lipid ratio, whereas under the same conditions
the WT peptide does not induce leakage even at rela-
tively high peptide/lipid ratios (Fig. 3). However, at low
pH both peptides induced similar leakage in liposomes.
Unlike the WT peptide, E11V/E15V is capable of promot-
ing extensive lipid mixing at neutral pH as well as at acid
pH (Fig. 4). Moreover, E11V/E15V and WT interact differ-
ently with membranes at neutral pH as shown by the
smaller shift in Th by the mutant. These data taken
ogether indicate that the E11V/E15V fusion peptide has
greater ability to penetrate more deeply into lipid mem-
ranes at pH values close to neutral than the WT fusion
eptide.
The apparent discrepancy between the effects of the
11V/E15V amino acid substitutions on the fusogenic
ctivity of intact HA and their effects on the penetration of
odel membranes by fusion peptides reveals an impor-
ant feature of the HA-mediated fusion process. The low
H triggers essentially two steps in the HA fusion reac-
ion: (i) A “spring-loaded” conformational change (Carr
nd Kim, 1993) leading to the dissociation of the HA1 top
omains (White and Wilson, 1987; Puri et al., 1990) and
ormation of an extended a-helical HA2 coiled-coil (Bul-
ough et al., 1994; Chen et al., 1999) that releases the
fusion peptide from its buried position in intact HA; (ii)
insertion of the exposed fusion peptide into target (Tsu-
rudome et al., 1992; Stegmann et al., 1991) and/or viral
membrane (Guy et al., 1992; Weber et al., 1994; Wharton
FIG. 7. Evidence for a simultaneous mechanism involving HA confo
consequences of a stepwise (A) or simultaneous mechanism (B). The
inserted fusion peptide (I), and simultaneously exposed and inserted (
25°C) a long pulse is applied (left), there will be sufficient fusion pepti
mutant HA at pH 7 and 37°C. If, on the other hand, a short pulse is prov
amount will be inserted to provide fusion at pH 7 and 37°C. However, si
may continue after switching to pH 7 and 37°C. According to the stepw
in the commitment experiments than WT. According to the simultaneoet al., 1995; Kozlov and Chernomordik, 1998; Bentz, 2000).
However, it is not known whether the conformationalchange occurs simultaneously with or subsequent to
membrane insertion of the fusion peptide (Weissenhorn
et al., 1999).
The spring-loaded conformational change must be
triggered by the protonation of certain residues in the HA
protein. The fact that the elimination of two of the acidic
amino acids in the fusion peptide has no effect on the pH
dependence of the conformational change as shown by
antibody binding (Steinhauer et al., 1995) and by changes
in bis-ANS fluorescence (Fig. 2) indicates that protona-
tion of residues outside of the fusion peptide must be the
trigger for the conformational change. The commitment
experiments (Fig. 6) provide information about the sub-
sequent interactions between HA2 and viral and/or tar-
get membrane following low pH activation of HA. We had
previously shown that the committed state is insensitive
to treatment with trypsin and DDT, which releases HA1,
but is reversed by treatment with proteinase K and ther-
molysin, which affect HA2 (Schoch et al., 1992). The
committed state thus represents interactions between
HA2, presumably including the fusion peptide, and the
target and/or viral membrane. Analysis of the commit-
ment data may then provide an answer to the question
whether the changes occur simultaneously or stepwise.
The analysis is diagramed schematically in Fig. 7. A low
pH pulse at 25°C triggers conformational changes and
release of fusion peptide in a population of HA mole-
cules. By switching back to neutral pH after a certain
window of time, further fusion peptide release is stopped
but the inserted fusion peptides are able to induce fusion
at pH 7.4 and 37°C (Schoch et al., 1992). If conformational
changes and fusion peptide insertion occur stepwise, we
reasoned that HA-E11V/E15V would more readily induce
al changes and fusion peptide insertion. The diagram illustrates the
text characters represent neutral HA (N), exposed fusion peptide (E),
presents HA-mediated fusion. If during the commitment phase (pH 5,
osed and inserted to provide the full extent of fusion for both WT and
ight), a population of fusion peptide will be exposed but an insufficient
V/E15V has the ability to penetrate membranes at neutral pH, insertion
chanism (A), we would then predict that HA-E11V/E15V is more active
hanism, we would predict no difference in commitment kinetics.rmation
boxed
EI). F re
de exp
ided (r
nce E11fusion after switching back to pH 7.4, since we have
shown that the E11V/E15V fusion peptide penetrates
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359FUSION PEPTIDE ACTIVITY OF THE INFLUENZA HEMAGGLUTININbilayers more readily at neutral pH. However, this is not
the case. HA-WT and HA-E11V/E15V display the same
kinetics of fusion at neutral pH and 37°C, after preexpo-
sure to pH 5 at 25°C (Fig. 6). Our data therefore provide
for the first time evidence that conformational changes in
HA are tightly coupled to fusion peptide insertion in the
overall HA-mediated fusion cascade.
MATERIALS AND METHODS
Materials
All lipids, including the fluorescently labeled lipids,
were purchased from Avanti Polar Lipids (Alabaster, AL).
The peptides, GLFGAIAGFIENGWEGMIDG-amide (WT)
and GLFGAIAGFIVNGWVGMIDG-amide (E11V/E15V),
were synthesized by Biosource (Hopkinton, MA) and
purified to .95% purity by HPLC. Calcein, calcein ace-
toxymethyl (AM) ester, octadecyl rhodamine B chloride
(R18), and 1,19-bis(4-anilino)naphtalene-5,59-disulfonic
acid (bis-ANS) were purchased from Molecular Probes
(Eugene, OR). Dulbecco’s modified Eagle’s medium
(DMEM) and fetal bovine serum (FBS) were purchased
from Biosource International (Camarillo, CA) and “Diluent
C”, a buffer which facilitates incorporation of fluorescent
probes into membranes, was purchased from Sigma (St.
Louis, MO). Fresh blood from healthy donors was ob-
tained from the NCI–Frederick Blood Bank and was used
within 3 days after sampling.
Differential scanning calorimetry (DSC)
Lipid films were made from dipalmitoleoyl phosphati-
dyl ethanolamine, and to some tubes small aliquots of a
peptide were also added from a methanolic solution. The
lipid films were suspended in either 20 mM PIPES, 1 mM
EDTA, 150 mM NaCl with 0.002% NaN3, pH 7.4 or in 10
M sodium citrate buffer, 1 mM EDTA, 140 mM NaCl, pH
.0 by vortexing at room temperature. The final lipid
oncentration was 7.5 mg/mL. The lipid suspension was
egassed under vacuum before being loaded into a
anoCal high-sensitivity scanning calorimeter (CSC,
rovo, UT). A heating scan rate of 0.75°/min was em-
loyed. The bilayer to hexagonal phase transition was
itted using parameters to describe equilibrium with a
ingle van’t Hoff enthalpy and the transition temperature
etermined as that for the fitted curve. Data were ana-
yzed with the program Origin 5.0.
reparation of lipid vesicles
Large unilamellar vesicles (LUV) were prepared from
OPC, DOPE, and Cholesterol (1:1:1) and when neces-
ary with 2 mol % of each N-Rho-PE and NBD-PE were
issolved in chloroform/methanol, 2/1 (v/v) at the desired
olar ratio. The lipid was deposited as a film on the wall
f a test tube by solvent evaporation with nitrogen. Final
races of solvent were removed for 2–3 h in a vacuum
hamber attached to a liquid nitrogen trap. The lipid filmsere suspended in the appropriate buffer by vortexing at
oom temperature. The lipid suspensions were further
rocessed with five cycles of freezing and thawing, fol-
owed by 10 passes through two stacked 0.1-mm poly-
arbonate filters (Nuclepore Corp., Pleasanton, CA) us-
ng the Mini extruder from Avanti. The lipid concentration
as determined with a phosphorous assay (Ames, 1966).
or leakage studies the liposomes were prepared in the
resence of 100 mM calcein. Unencapsulated calcein
as removed using a Bio-Gel A 5-m agarose gel (Bio-
ad, Hercules, CA) column. “Raft” liposomes used for leak-
ge studies contained 2:1:1:2 (mole ratio) liver or brain
C:sphingomyelin:cerebrosides:cholesterol (Schroeder
t al., 1998).
ipid mixing assay for membrane fusion
The resonance energy transfer assay of Struck et al.
1981) was used to monitor membrane fusion. LUVs were
repared containing DOPC:DOPE:Cholesterol at a molar
atio of 1:1:1. For each of these lipid systems two popu-
ations of LUVs were prepared, one unlabeled and one
abeled with 2 mol % each of N-(lissamine Rhodamine B
ulfonyl) phosphatidylethanolamine (N-Rh-PE) and N-(7-
itro-2,1,3-benzoxadiazol-4-yl) phosphatidylethanolamine
N-NBD-PE). A 9:1 molar ratio of unlabeled to labeled
iposomes was used in the assay. Fluorescence was
ecorded at excitation and emission wavelengths of 465
nd 530 nm, respectively, using a 490 nm cut-off filter
laced between the cuvette and the emission monochro-
ator, with 4-nm bandwidths, using an SLM Aminco
owman AB-2 spectrofluorometer. Siliconized glass cu-
ettes (1 cm2) were used with continuous stirring in a
thermostated cuvette holder. Measurements were car-
ried out using a buffer containing 5 mM HEPES, 5 mM
Mes, 5 mM citric acid, 0.15 M NaCl, and 1 mM EDTA, pH
7.0. LUVs at a final lipid concentration of 150 mM were
dded to 2 mL of buffer in the cuvette at 37°C and then
he peptide was injected from a solution of DMSO. For
easurements at pH 5, the contents of the cuvette con-
aining liposomes was acidified to pH 5 by the addition of
0 mL of 1 mM citric acid prior to the addition of peptide.
Fluorescence was recorded for several minutes and then
20 mL 10% Triton X-100 was added (final concentration
.1%). The initial residual fluorescence intensity, prior to
cidification, F0, was taken as zero. The maximum fluo-
escence intensity, Fmax, was obtained by dilution of the
abeled lipids with 20 mL 10% Triton X-100. Percentage
ipid mixing at time t is given by [(Ft 2 F0)/(Fmax 2 F0)] 3
100. All runs were done in duplicate and were found to
be in close agreement. Controls were done using com-
parable volumes of DMSO in the absence of peptide. The
intensity of maximal fluorescence with Triton was found
to be close to that obtained when the mole fraction of
labeled lipids was reduced by 10-fold with unlabeled
lipid and was taken as the fluorescence corresponding
to 100% fusion.
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360 KORTE ET AL.Measurement of peptide induced leakage of calcein
from liposomes
The assay is based on self-quenching properties of
the water-soluble dye (Weinstein et al., 1977). The fluoro-
hore trapped at high concentration inside a liposome
mits only a few percentages of the fluorescence that it
ould if released and diluted into the surrounding me-
ium. Calcein-loaded LUVs at a final lipid concentration
f 1.3 mM were added to 2 ml of sodium acetate (NaAc)
buffer (20 mmol/l NaAc, 130 mmol/l NaCl) (pH , 6.0) with
preadjusted pH and temperature and after 120 s the
peptide was injected from a solution of DMSO. Fluores-
cence was recorded (excitation and emission wave-
lengths of 490 and 525 nm, respectively) for 15–20 min
and then 10 ml 10% Triton X-100 was added (final con-
centration 0.05%) to obtain the maximum fluorescence
intensity, Fmax. The initial residual fluorescence intensity,
prior to addition of peptide, F0, was taken as zero. Per-
entage leakage at time t is given by [(Ft 2 F0)/(Fmax 2
F0)] 3 100. Controls were done using comparable vol-
mes of DMSO in the absence of peptide.
luorescence labeling of erythrocytes
Labeling of human erythrocytes with calcein-AM was
one as follows: A solution of calcein-AM (50 mg solubi-
ized in 10 ml DMSO and further diluted with 40 ml of 137
M NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4
pH 7.4 (PBS)) was incubated with 1 ml suspension of
washed erythrocytes (10% 5 109/ml in PBS) at 37°C for
45–60 min with occasional stirring. At the end of incuba-
tion, the cells were pelleted by centrifugation and
washed with PBS (10 ml 3 3). Calcein-labeled cells were
resuspended in 10 ml PBS at 108/ml 5 1% erythrocyte
uspension. Calcein-loaded erythrocytes were further di-
uted in DMEM at 2 3 107/ml 5 0.2% erythrocyte just
before binding to cells infected with vaccinia recombi-
nants (see below). For the peptide-induced leakage ex-
periments 100 mM calcein-AM was used to obtain self-
uenching concentrations of the dye in the erythrocytes.
easurement of leakage of calcein from erythrocytes
as performed as above using 5 ml of the 2% erythrocyte
tock added to 2 ml of buffer.
To measure lipid mixing as a result of HA-mediated
usion, erythrocytes were labeled with R18 (Morris et al.,
989). Five microliters of R18 stock (1 mg/ml in ethanol),
iluted in 200 ml of Diluent C, was added to the erythro-
ytes. The labeled erythrocytes were incubated for 15
in at room temperature in the dark, washed five times
ith PBS, and resuspended in 5 ml PBS (erythrocyte
oncentration 5 2%) and stored at 4°C for further use.
Expression of HA on the cell surface using vaccinia
recombinantsNIH 3T3 cells were infected with recombinant vaccinia
expressing wild-type X-31 hemagglutinin (HA-WT) andE11V/E15V mutant X-31 hemagglutinin (HA-E11V/E15V)
(Steinhauer et al., 1995), kindly provided by David Stein-
hauer. Prior to infection, the vaccinia virus was incubated
1:1 with 0.25 mg/ml trypsin for 30 min at 37°C, while
vortexing every 10 min. The vaccinia recombinants were
added to 3 ml DMEM 1 2% FBS, layered over 75%
confluent NIH3T3 plated cells in Costar 75 cm2 plastic
lasks (Corning Inc., Life Sciences, Acton, MA) at a m.o.i.
f 2–5 and incubated for 2 h at 37°C. The cells were then
ncubated for 12 h at 37°C in 10 ml of DMEM 1 10% FBS.
ctivation of HA and binding of erythrocytes
The HA0-expressing cells were treated with 2 ml PBS
ontaining 5 mg/ml trypsin and 1 U/ml neuraminidase for
3 min at room temperature, and cells were washed two
times with DMEM (10% FBS). For fusion experiments, 5
ml of the erythrocyte suspension, diluted to 0.2% with
DMEM (2% FBS), was added to each flask and incubated
for 15 min at room temperature. Unbound erythrocytes
were removed by washing five times with PBS. Cells
were then washed one time with PBS w/o calcium/
magnesium and removed from the flask by treatment
with 1.5 ml enzyme-free dissociation solution for 3–5 min
at 37°C. The NIH3T3–erythrocyte complexes were
washed two times with DMEM (10% FBS) by centrifuga-
tion, resuspended in 150 ml DMEM (10% FBS), and stored
n ice for further use.
easurement of cell fusion activity
Twenty microliters of NIH3T3 cells with bound eryth-
ocytes were added to 2 ml NaAc buffer with preadjusted
H in a temperature-controlled cuvette. Fluorescence
as recorded under continuous stirring with a 2 3 8-mm
Teflon-coated stir bar using a SLM8000 spectrofluorom-
eter at excitation and emission wavelengths of 560 and
590 nm, respectively (575-nm cut-off filter). Fluorescence
was recorded for 15 min and then 10 ml of 10% Triton
X-100 was added (final concentration 0.05%) to obtain the
maximum fluorescence intensity (Fmax). The initial resid-
ual fluorescence intensity (F0) at pH , 7.4 was calculated
ased on the ratio of final intensity after incubation for 15
in and Fmax at pH 7.4. Percentage fluorescence de-
uenching (FDQ) at time t is given by [(Ft 2 F0)/(Fmax 2
0)] 3 100.
easurement of bis-ANS fluorescence changes in
A-expressing cells
Twenty microliters of HA-expressing cells were added
o 2 ml NaAc buffer with preadjusted pH containing 2.5
mg/ml bis-ANS. Fluorescence was recorded under con-
tinuous stirring with a 2 3 8-mm Teflon-coated stir bar in
a temperature-controlled cuvette using a SLM8000 spec-
trofluorometer at excitation and emission wavelengths of
400 and 490 nm, respectively. Fluorescence was re-
corded for 15 min.
361FUSION PEPTIDE ACTIVITY OF THE INFLUENZA HEMAGGLUTININACKNOWLEDGMENTS
We are very grateful to Dr. David Steinhauer for providing the vac-
cinia recombinants expressing HA-WT and HA-E11V/E15V. We also
thank members of the Blumenthal Lab for fruitful discussions and
continuous help during this study.
REFERENCES
Ames, B. N. (1966). Assay of inorganic phosphate, total phosphate and
phosphatases. Methods Enzymol. 8, 115–118.
Bentz, J. (2000). Membrane fusion mediated by coiled coils: A hypoth-
esis. Biophys. J. 78, 886–900.
Blumenthal, R., Schoch, C., Puri, A., and Clague, M. J. (1991). A dissec-
tion of steps leading to viral envelope protein-mediated membrane
fusion. Ann. NY Acad. Sci. 635, 285–296.
Bullough, P. A., Hughson, F. M., Skehel, J. J., and Wiley, D. C. (1994).
Structure of influenza haemagglutinin at the pH of membrane fusion.
Nature 371, 37–43.
Carr, C. M., and Kim, P. S. (1993). A spring-loaded mechanism for the
conformational change of influenza hemagglutinin. Cell 73, 823–832.
Chen, J., Skehel, J. J., and Wiley, D. C. (1999). N- and C-terminal residues
combine in the fusion-pH influenza hemagglutinin HA(2) subunit to
form an N cap that terminates the triple-stranded coiled coil. Proc.
Natl. Acad. Sci. USA 96, 8967–8972.
Clague, M. J., Schoch, C., and Blumenthal, R. (1991). Delay time for
influenza virus hemagglutinin-induced membrane fusion depends on
hemagglutinin surface density. J. Virol. 65, 2402–2407.
Durell, S. R., Martin, I., Ruysschaert, J. M., Shai, Y., and Blumenthal, R.
(1997). What studies of fusion peptides tell us about viral envelope
glycoprotein-mediated membrane fusion (review). Mol. Membr. Biol.
14, 97–112.
Epand, R. M., and Epand, R. F. (1994). Relationship between the infec-
tivity of influenza virus and the ability of its fusion peptide to perturb
bilayers. Biochem. Biophys. Res. Commun. 202, 1420–1425.
Guy, H. R., Durell, S. R., Schoch, C., and Blumenthal, R. (1992). Analyzing
the fusion process of influenza hemagglutinin by mutagenesis and
molecular modeling. Biophys. J. 62, 95–97.
Han, X., and Tamm, L. K. (2000). A host-guest system to study structure-
function relationships of membrane fusion peptides. Proc. Natl.
Acad. Sci. USA 97, 13097–13102.
Klenk, H. D., Rott, R., Orlich, M., and Blodorn, J. (1975). Activation of
influenza A viruses by trypsin treatment. Virology 68, 426–439.
Korte, T., and Herrmann, A. (1994). pH-dependent binding of the fluoro-
phore bis-ANS to influenza virus reflects the conformational change
of hemagglutinin. Eur. Biophys. J. 23, 105–113.
Kozlov, M. M., and Chernomordik, L. V. (1998). A mechanism of protein-
mediated fusion: Coupling between refolding of the influenza hem-
agglutinin and lipid rearrangements. Biophys. J. 75, 1384–1396.
Morris, S. J., Sarkar, D. P., White, J. M., and Blumenthal, R. (1989).
Kinetics of pH-dependent fusion between 3T3 fibroblasts expressing
influenza hemagglutinin and red blood cells. Measurement by de-
quenching of fluorescence. J. Biol. Chem. 264, 3972–3978.
Puri, A., Booy, F., Doms, R. W., White, J. M., and Blumenthal, R. (1990).
Conformational changes and fusion activity of influenza hemagglu-
tinin of the H2 and H3 subtypes: Effects of acid pretreatment. J. Virol.
64, 3824–3832.
Scheiffele, P., Rietveld, A., Wilk, T., and Simons, K. (1999). Influenza
viruses select ordered lipid domains during budding from the plasma
membrane. J. Biol. Chem. 274, 2038–2044.Schoch, C., and Blumenthal, R. (1993). Role of the fusion peptide
sequence in initial stages of influenza hemagglutinin-induced cell
fusion. J. Biol. Chem. 268, 9267–9274.
Schoch, C., Blumenthal, R., and Clague, M. J. (1992). Identification and
characterization of a long lived state for influenza virus-erythrocyte
complexes committed to fusion a neutral pH. FEBS Lett. 311, 221–
225.
Schroeder, R. J., Ahmed, S. N., Zhu, Y., London, E., and Brown, D. A.
(1998). Cholesterol and sphingolipid enhance the Triton X-100 insol-
ubility of glycosylphosphatidylinositol-anchored proteins by promot-
ing the formation of detergent-insoluble ordered membrane do-
mains. J. Biol. Chem. 273, 1150–1157.
Skehel, J. J., Bayley, P. M., Brown, E. B., Martin, S. R., Waterfield, M. D.,
White, J. M., Wilson, I. A., and Wiley, D. C. (1982). Changes in the
conformation of influenza virus hemagglutinin at the pH optimum of
virus-mediated membrane fusion. Proc. Natl. Acad. Sci. USA 79,
968–972.
Skehel, J. J., and Wiley, D. C. (1998). Coiled coils in both intracellular
vesicle and viral membrane fusion. Cell 95, 871–874.
Skehel, J. J., and Wiley, D. C. (2000). Receptor binding and membrane
fusion in virus entry: The influenza hemagglutinin. Annu. Rev. Bio-
chem. 69, 531–569.
Stegmann, T., Delfino, J. M., Richards, F. M., and Helenius, A. (1991). The
HA2 subunit of influenza hemagglutinin inserts into the target mem-
brane prior to fusion. J. Biol. Chem. 266, 18404–18410.
Steinhauer, D. A., Wharton, S. A., Skehel, J. J., and Wiley, D. C. (1995).
Studies of the membrane fusion activities of fusion peptide mutants
of influenza virus hemagglutinin. J. Virol. 69, 6643–6651.
Struck, D. K., Hoekstra, D., and Pagano, R. E. (1981). Use of resonance
energy transfer to monitor membrane fusion. Biochemistry 20, 4093–
4099.
Tsurudome, M., Gluck, R., Graf, R., Falchetto, R., Schaller, U., and
Brunner, J. (1992). Lipid interactions of the hemagglutinin HA2 NH2-
terminal segment during influenza virus-induced membrane fusion.
J. Biol. Chem. 267, 20225–20232.
Weber, T., Paesold, G., Galli, C., Mischler, R., Semenza, G., and Brunner,
J. (1994). Evidence for H(1)-induced insertion of influenza hemagglu-
tinin HA2 N-terminal segment into viral membrane. J. Biol. Chem.
269, 18353–18358.
Weinstein, J. N., Yoshikami, S., Henkart, P., Blumenthal, R., and Hagins,
W. A. (1977). Liposome-cell interaction: Transfer and intracellular
release of a trapped fluorescent marker. Science 195, 489–492.
Weissenhorn, W., Dessen, A., Calder, L. J., Harrison, S. C., Skehel, J. J.,
and Wiley, D. C. (1999). Structural basis for membrane fusion by
enveloped viruses. Mol. Membr. Biol. 16, 3–9.
Wharton, S. A., Martin, S. R., Ruigrok, R. W., Skehel, J. J., and Wiley, D. C.
(1988). Membrane fusion by peptide analogues of influenza virus
haemagglutinin. J. Gen. Virol. 69, 1847–1857.
Wharton, S. A., Calder, L. J., Ruigrok, R. W., Skehel, J. J., Steinhauer, D. A.,
and Wiley, D. C. (1995). Electron microscopy of antibody complexes
of influenza virus haemagglutinin in the fusion pH conformation.
EMBO J. 14, 240–246.
White, J. M., and Wilson, I. A. (1987). Anti-peptide antibodies detect
steps in a protein conformational change: Low-pH activation of the
influenza virus hemagglutinin. J. Cell Biol. 105, 2887–2896.
Wilson, I. A., Skehel, J. J., and Wiley, D. C. (1981). Structure of the
haemagglutinin membrane glycoprotein of influenza virus at 3 A
resolution. Nature 289, 366–373.
